XML 24 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Changes in Stockholders' / Members’ Equity - USD ($)
$ in Millions
Total
Class A Common Stock
Class B Common Stock
Members' Equity
Members' Equity
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Additional paid-in capital
Non-controlling interest
Retained earnings (Accumulated deficit)
Beginning balance at Dec. 31, 2018       $ 284.0 $ (0.2)          
Increase (Decrease) in Members' Equity [Roll Forward]                    
Contribution of Remedy       698.3            
Acquisition of TAV Health       26.1            
Member contributions       3.0            
Member distributions       (22.5)            
Repurchase of member units       (2.7)            
Tax payments on behalf of members       (5.1)            
Equity-based compensation       4.5            
Proceeds from exercises of stock options       0.7            
Net loss $ (28.5)     (28.5)            
Ending balance at Dec. 31, 2019       957.6            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Proceeds from exercises of stock options       0.7            
Net income (28.5)     (28.5)            
Member distributions       (8.2)            
Repurchase of member units       (56.9)            
Tax payments on behalf of members       1.0            
Equity-based compensation       12.1            
Proceeds from exercises of stock options       3.5            
Repurchase of stock on behalf of New Remedy Corp       (0.6)            
Net loss (14.5)     (14.5)            
Ending balance at Dec. 31, 2020 894.0     894.0            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Proceeds from exercises of stock options       3.5            
Net income (14.5)     (14.5)            
Ending balance (in shares) at Dec. 31, 2020   0 0              
Increase (Decrease) in Members' Equity [Roll Forward]                    
Net loss 9.9                  
Ending balance at Dec. 31, 2021       $ 0.0            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 9.9                  
Ending balance at Dec. 31, 2021 $ 1,492.9         $ 1.7 $ 0.6 $ 1,101.3 $ 369.6 $ 19.7
Ending balance (in shares) at Dec. 31, 2021   170,987,365 56,838,744     170,987,365 56,838,744